Phase I clinical trial shows treatment design
Scientists at Wake Forest University School of Medicine are reporting results from a Phase I trial in an area of promising research for Alzheimer's disease—cellular senescence.
Stay updated with breaking news from Mcgill Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Scientists at Wake Forest University School of Medicine are reporting results from a Phase I trial in an area of promising research for Alzheimer's disease—cellular senescence.
Scientists at Wake Forest University School of Medicine are reporting results from a Phase I trial in an area of promising research for Alzheimer's disease—cellular senescence.
Their economic power to try to get what they need from a society. so i actually admire that. it was very strategic and, particularly, for example, to mcgill and the people from the mcgill foundation have done a brilliant job. but at the end of the day, if you're in an arms race with the republican donors, you're going to lose. >> and i think it's important to remember that, look, in new york, you saw a situation where republican donors got together with a democratic donor to push through the progress that was passed here. and i think that ultimately, one of the defining parts that's not talked...